4519.T
CHUGAI PHARMACEUTICAL CO.,LTD.
プライム · 医薬品 · 医薬品 · JP
JPY 6,878.00
+0.67%Year over year
Reported trailing growth
- Revenue
- +5.7%
- EBITDA
- —
- EBIT
- +7.3%
- EPS
- +10.2%
- Free cash flow
- +6.1%
- Operating cash flow
- +6.8%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -0.1%
- EBITDA
- —
- EBIT
- +3.9%
- Net income
- +5.0%
- EPS
- +5.0%
- Free cash flow
- +19.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026